Product Information

TERCONAZOLE 80 MG SUPPOSITORY is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $17.9278 per EA under NDC 45802071708. Its NADAC has been published 678 times since Nov 28, 2013.

FDA first approved this application on Mar 17, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TERCONAZOLE 80 MG SUPPOSITORY

Terconazole
$17.9278per EA

Strength

80 mg/1

NDC

45802071708

Classification

Generic

Dosage Form

SUPPOSITORY

Route

VAGINAL

Effective Date

11/18/2026

Active Ingredients

TERCONAZOLE

Approval Type

Generic (ANDA)

FDA Application

ANDA077149

FDA Approved

3/17/2006

TE Code

AB

On Market Since

8/28/2006

Pharmacological Classes

Price Statistics

The NADAC for TERCONAZOLE 80 MG SUPPOSITORY has been published 678 times since Nov 28, 2013, and over the history we have for it it has declined 28.0%. The table below summarizes its recorded NADAC range and movement.

Current price$17.9278 per EA
All-time high$30.5327 (Mar 11, 2020)
All-time low$14.7277 (Jul 20, 2022)
52-week high$21.5982
52-week low$17.6287
Median price$23.2448
Average price$22.2784
Largest weekly change-40.1% (May 22, 2024)
Weeks tracked678
Tracking sinceNov 28, 2013

Price History

1W

-5.0%

1M

-3.7%

3M

-2.4%

6M

-17.0%

1Y

+1.7%

3Y

-4.9%

5Y

-16.8%

All

-28.0%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TERCONAZOLE 80 MG SUPPOSITORY?

The current National Average Drug Acquisition Cost (NADAC) for TERCONAZOLE 80 MG SUPPOSITORY, manufactured by Padagis Israel Pharmaceuticals Ltd, is $17.9278 per EA (NDC 45802071708), effective Nov 18, 2026.

How has the price of TERCONAZOLE 80 MG SUPPOSITORY changed over time?

Over the history we have for it, the NADAC for TERCONAZOLE 80 MG SUPPOSITORY has declined 28.0%. It has been tracked across 678 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for TERCONAZOLE 80 MG SUPPOSITORY?

Since Nov 28, 2013, the NADAC for TERCONAZOLE 80 MG SUPPOSITORY has ranged from a low of $14.7277 (Jul 20, 2022) to a high of $30.5327 (Mar 11, 2020), with a median of $23.2448 per EA.

Are there cheaper alternatives to TERCONAZOLE 80 MG SUPPOSITORY?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TERCONAZOLE 80 MG SUPPOSITORY in a comparable dosage form, but none are currently priced below it.

Who manufactures TERCONAZOLE 80 MG SUPPOSITORY?

TERCONAZOLE 80 MG SUPPOSITORY (NDC 45802071708) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.